Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga/18F-FAPI-04 PET-MRI in Myocardial Fibrosis
NCT05867589Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- May 2023
- Primary completion
- Dec 2025
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Open-label trial of 68Ga/18F-FAPI-04 in myocardial fibrosis, sponsored by Nanjing First Hospital. Primary endpoint: Standardized Uptake Value at 31 months. Started May 2023; status: recruiting.
02
Drugs
68Ga/18F-FAPI-04
03
Conditions
myocardial fibrosis
Beyond the preview
Go deeper on NCT05867589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05867589.